1[1]OReilly MS, Holmgren L, Shing Y et al. Angiostatin:A novel angiogenesis inhibitor that mediates the suppression of metasta ses by a Lewis lung carcinoma, Cell, 1994;79(2) :315～28
2[2]OReilly MS, Boehm T, Shing Y et al. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth, Cell, 1997;88 (2):277～85
3[3]Standker L, Schrader M, Kanse SM et al. Isolation and charac terization of the circulating from of human endostatin, FEBSLett, 1997;420(2～3) :129～33
4[4]Ferreras M, Felbor U, Lenhard T et al. Generation and degradation of human endostatin proteins by variors proteinases. FEBS Lett, 2000 ;486(3) :247～51
5[5]Iughetti P, Suzuki O, Godoi PHC et al. A polymorphism in en dostatin, an angigenesis inhibitor, predisposes for the development of prostatic adenocarcinoma. Cancer Res, 2001; 61 (20): 7375～8
6[6]Miosge N, Sasaki T, Timpl R. Angiogenesis inhibitor endostatin is a distinct component of elastic fibers in vessel walls. Faseb J, 1999;13(13) :1743～50
7[7]Annual meeting, American society of clinical oncology (ASCO), May, 2001. San Francisco of California
8[8]Kasai S, Nagasawa H, Shimamura M et al. Design and synthesis of antiangiogenic/heparin-binding arginine dendrimer mimicking the surface of endostatin. Bioorganic & Medicinal Chemistry Letters, 2002 ; 12:951 ～ 4
9[9]Hohenester E,Sasaki T ,Mann K et al. Variable zinc coordination in endostatin. J Mol Biol, 2000; 297 (1): 1 ～ 6
10[10]Yamaguchi N, Anand-Apte B, Lee Metal. Endostatin inhibits VEGF-induced endothelial cell migration and rumor growth inde pendently of zinc binding. The EMBO J, 1999; 18(16) :4414～23
9O'Reilly M S, Boehm T, Shing Y,et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth[ J ]. Cell, 1997, 88 (2) :277 -85.
10Standker L, Schrader M, Kanse S M, et al. Isolation and characterization of the circulating form of human endostatin [ J ]. FEBS Lett,1997,420 (2-3) :129-3.
